Ethics of newborn screening
Summary
Newborn screening for phenylketonuria has been available since the early 1960s. Advances in technology such as the introduction of tandem mass spectrometry have increased the number of conditions we are now able to screen for. More recently the possibility of genetic profiling of the newborn has been raised. This article looks at these changes and discusses some of the ethical issues that they raise.
Keywords: Newborn, Screening, Guthrie, Metabolic, Genetic
To access this article, please choose from the options below
PII: S0957-5839(06)00038-8
doi:10.1016/j.cupe.2006.03.002
© 2006 Elsevier Ltd. All rights reserved.

